A study into the ‘next day’ performance of people given an oil containing THC and CBD has found that cannabis has no significant impact on safety-sensitive tasks such as driving a vehicle. Cannabis, specifically the THC contained within, is well known to produce an effect on [...]
Events will take place at several major cities around the UK to raise awareness and bring medical cannabis education directly to the public. Patient advocates will visit Belfast, Birmingham, Glasgow, Cardiff and London throughout Medical Cannabis Awareness Week (1-7 November), to share their personal experiences and [...]
A parliamentary committee has recommended that cannabis should be partially legalised and accessed through social clubs in Ireland. The committee, set up to guide Ireland’s future drug legislation, said that personal possession of all drugs should be decriminalised and the country’s approach to drug use should [...]
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re committed to providing the highest standard of medical cannabis care, guided by science. As such, we are concerned about the growing number of people buying cannabis from illegal sources, including online [...]
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind. After almost six years of medical cannabis being available on prescription in the UK, the numbers [...]
Prescribing medical cannabis for chronic pain could save the NHS almost £4 billion annually, according to new research. The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain, undertaken by York Health-Economics Consortium at the University of York. Researchers [...]
Increasing access to medical cannabis on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study published by the Cannabis Industry Council (CIC). The study, published in the peer-reviewed journal Expert Review of Pharmacoeconomics & [...]
The majority of doctors in Germany can now prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies. It comes amid reports suggesting the German pharmacies are now key beneficiaries of the medical cannabis market, bringing in tens of thousands of euros [...]
A study by researchers at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center (BMC) has found that cannabis use among young adults in the country of Georgia did not increase following legalisation. The use of cannabis was legalised for adults over the [...]
A study has found that a single high dose of psilocybin can lead to physical changes in the human brain. The study, which is in pre-print and has not yet been peer-reviewed, involved 28 healthy participants who had no prior experience with psilocybin or other psychedelics. [...]
The Cannabis Industry Council (CIC) has published a good practice guide for prescription cannabis clinics in the UK. The guidance includes 10 principles of good practice and five specific policies for clinics to implement. The good practice guide encourages ethical and responsible operations, builds industry collaboration, [...]
UK medical cannabis experts have published a comprehensive review of evidence for the prescription of cannabis-based medicines in epilepsy. With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy, published by Maple Tree Consultants, provides the first review of nearly 100 clinical trials, real-world studies, and [...]
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. [...]
By Sarah Sinclair with additional reporting from Ben Stevens (Business of Cannabis) Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy. The first significant update on the trials—first promised in [...]
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion. According to the latest figures from the NHS Business Services Authority (NHSBSA), published in response to an FOI request, the number of [...]
A study, published in the Journal of Cannabis Research, has found that the legalisation of cannabis is linked with higher levels of physical activity. In the study, researchers from Brigham Young University used data from the Behavior Risk Factor Surveillance System (BRFSS) to evaluate the association between [...]
A first-of-its-kind study, published in the American Journal of Preventive Medicine, has shown that the cessation of cigarette smoking can increase life expectancy, regardless of age. In the study, researchers at the University of Michigan School of Public Health analysed average death rates by age and [...]
Ukraine’s Ministry of Health has approved the draft list of conditions for which medical cannabis can now be prescribed, excluding PTSD and other mental health disorders until more research is available. The impact of trauma and PTSD following Russia’s invasion of Ukraine played a key role [...]
A group of researchers from the Toronto Metropolitan University have conducted a study investigating the effect cannabis can have on a person’s experience of music. The preprint study involved participants 104 participants and used questionnaires and in-depth interviews. Researchers concluded that people do enjoy music more when [...]
The THC-based drug dronabinol has been shown to reduce agitation in Alzheimer’s patients without adverse effects. Researchers have shown that a pill form of the drug dronabinol, an FDA-approved synthetic version of THC, reduces agitation in patients with Alzheimer’s by an average of 30%. The researchers [...]
States in the US where cannabis is available legally see fewer prescriptions issued for benzodiazepines, research has shown. A study, published in the journal JAMA Network Open, found that when cannabis is legally accessible, either on a medical prescription or via recreational outlets, there is a [...]
Spanish regulators have taken another step towards introducing the country’s long-delayed medical cannabis framework, but patients say the legislation does not go far enough. On Monday 30 September, the Ministry of Health published a draft royal decree for public hearing, setting out the proposed regulations for [...]
Drug policy experts are calling for national education programs to tackle the lack of awareness and ‘stigmatising attitudes’ towards medical cannabis patients. In a new paper, researchers from Liverpool John Moores University, have highlighted how current policies, and a lack of training for professionals, are contributing [...]
Regulating and legalising cannabis for adult use could net the UK Treasury between £3.3 billion pa and £9.5 billion per annum, according to a plan published by CLEAR. The plan, titled How To Regulate Cannabis in Britain is the third iteration of research conducted by CLEAR [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
